Definitive Contract 75F40123C00111

Award Date 9/22/23
Potential Completion Date 9/24/24
Potential Value $4.1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Food and Drug Administration (FDA) awarded a $3,821,128.80 firm-fixed-price contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. This contract is part of the FDA's Center for Devices and Radiological Health's (CDRH) Medical Data Enterprise Initiative, which aims to streamline the use of real-world data and integrate it with CDRH data. ICA will provide advanced data analytics, artificial intelligence, healthcare...
This contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $4,224,342.40 Firm Fixed Price Definitive Contract is for CDRH MDE AI PRESCRIPTIVE ANALYTICS services, with an ultimate completion date of September 24, 2024. The contract was awarded as an 8(a) Sole Source. ICA is a specialized provider of advanced data analytics, artificial...
This $3,976,584.00 firm fixed price federal contract was awarded to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business, by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS). The 2-year contract, titled "CDRH REAL-WORLD DATA ANALYSES," is for ICA to provide advanced data analytics, artificial intelligence, healthcare IT, and management consulting services...
This is a $3,539,788.80 firm-fixed price definitive contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the scale-up of an existing Medical Device Evaluation (MDE) Artificial Intelligence (AI) pilot to an operational tool. ICA has an extensive track record supporting federal health agencies like HHS and...
This is a $4,174,814.40 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for the development of an artificial intelligence (AI) tool to predict alerts related to medical devices under the Center for Devices and Radiological Health (CDRH). This sole-source, 8(a) set-aside contract will run through September 24, 2024. ICA is...
This is a $3,920,678.40 firm-fixed-price definitive contract awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for the development of a medical device predictive analytics tool to support the FDA's regulatory decision-making processes. The contract is an 8(a) sole source award, which means it was set aside for eligible 8(a) program...
This is a $4,294,646.40 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA) to develop a Center for Devices and Radiological Health (CDRH) Medical Device AI Data Lake with Real-World Data. ICA is an SBA-certified 8(a), minority-owned, small disadvantaged business that specializes in healthcare data analytics, medical device evaluation, and AI solutions for federal health agencies. The contract has a firm fixed-price...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price definitive contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business, to provide a natural language querying module for the Center for Devices and Radiological Health (CDRH). The $3,703,521.60 contract was awarded on September 14, 2022, with a completion date of March 19, 2024. ICA has extensive experience...
This is a $4,456,062.35 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for support to conduct 10 post-market safety studies, with a period of performance through August 29, 2025. ICA has an extensive track record of delivering a wide range of healthcare IT, data analytics, and management consulting services to federal...
This federal contract award for $3,885,609.18 was issued by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services (HHS), to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for literature analysis services to support the Center for Devices and Radiological Health (CDRH) within the FDA. This is a definitive, firm fixed-price contract with a completion date...

The U.S. Food and Drug Administration (FDA) has awarded a $4,077,696.00 Firm Fixed Price, Definitive Contract to International Consulting Associates, Inc. (ICA) to develop AI-enabled user workflows and dashboards for the Center for Devices and Radiological Health (CDRH). This 8(a) sole source contract, running through September 2024, is part of the FDA's broader "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative. ICA, an SBA-certified 8(a), minority-owned, small disadvantaged business, will leverage its expertise in healthcare data analytics, medical device safety, and emerging technologies to deliver solutions that modernize the FDA's medical product evaluation and monitoring capabilities, including predictive modeling and post-market safety surveillance tools. This contract award builds on ICA's extensive track record of supporting critical health initiatives across federal agencies, particularly within the Department of Health and Human Services (HHS) and its operating divisions like the FDA and Centers for Medicare and Medicaid Services (CMS).

Generated 1/22/25, 9:22 AM